Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China · Delayed Price · Currency is CNY 31.23
-0.12 (-0.38%)
Mar 20, 2026, 3:00 PM CST
SHA:600976 Revenue
Jianmin Pharmaceutical Group had revenue of 747.33M CNY in the quarter ending September 30, 2025, a decrease of -14.27%. This brings the company's revenue in the last twelve months to 3.18B, down -20.15% year-over-year. In the year 2024, Jianmin Pharmaceutical Group had annual revenue of 3.50B, down -16.81%.
Revenue (ttm)
3.18B
Revenue Growth
-20.15%
P/S Ratio
1.51
Revenue / Employee
1.35M
Employees
2,345
Market Cap
4.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.50B | -708.17M | -16.81% |
| Dec 31, 2023 | 4.21B | 572.35M | 15.72% |
| Dec 31, 2022 | 3.64B | 341.37M | 10.35% |
| Dec 31, 2021 | 3.30B | 843.43M | 34.34% |
| Jan 1, 2021 | 2.46B | 217.06M | 9.69% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinhe Biotechnology CO., LTD. | 2.75B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Yabao Pharmaceutical Group | 2.27B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.74B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.32B |
| Tibet Weixinkang Medicine | 1.17B |